Norovirus Vaccine (Virus-Like Particles) from Mexico
This norovirus vaccine candidate uses virus-like particles (VLPs) produced by recombinant technology to mimic the viral capsid and induce immunity. It is designed to prevent acute gastroenteritis caused by norovirus. As a biotechnologically obtained vaccine, it is classified under tariff item 3002.49.00 as an 'other' vaccine.
Duty Rate — Mexico → Canada
0%
Import Tips
• If the vaccine is investigational, obtain a Clinical Trial Application (CTA) approval from Health Canada
• Provide documentation of the recombinant production process
• Ensure the product is shipped with proper cold-chain management and log all temperature data